Literature DB >> 1795399

Differences in the abilities of human tau isoforms to promote microtubule assembly.

C W Scott1, D P Blowers, P T Barth, M M Lo, A I Salama, C B Caputo.   

Abstract

Three isoforms of human tau protein were compared for their abilities to induce microtubule assembly. The three isoforms, tau 3 (tau containing three microtubule-binding domains), tau 4 (tau containing four microtubule-binding domains) and tau 4L (tau containing four microtubule binding domains plus a 58-amino-acid insert near the N-terminus) were expressed in E. coli and purified using ammonium sulfate precipitation, ion exchange, and size exclusion chromatography. All three isoforms induced microtubule assembly at micromolar concentrations and showed similar critical concentrations for assembly of 0.4-0.45 microM. However, tau 4 induced microtubule formation at a rate five- to tenfold faster than either tau 3 or tau 4L. The rate of microtubule elongation seen with tau 4 was twofold greater than with tau 3 or tau 4L, suggesting that the faster rate of microtubule assembly seen with tau 4 was due, at least in part, to faster elongation. Tau 4 induced a greater number of microtubules to form at steady state than did tau 3 or tau 4L. The microtubules generated with each tau isoform had similar steady-state length distributions and were equally susceptible to cold-induced disassembly. These results indicate that the additional microtubule-binding domain in tau 4 enhances microtubule assembly, while the 58-amino-acid insert negates the stimulatory effect of the fourth microtubule-binding domain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1795399     DOI: 10.1002/jnr.490300116

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

Review 1.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

Review 2.  Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.

Authors:  Dick Terwel; Ilse Dewachter; Fred Van Leuven
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

3.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

4.  Respective roles of neurofilaments, microtubules, MAP1B, and tau in neurite outgrowth and stabilization.

Authors:  T B Shea; M L Beermann
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

5.  Three repeat isoforms of tau inhibit assembly of four repeat tau filaments.

Authors:  Stephanie J Adams; Michael A DeTure; Melinda McBride; Dennis W Dickson; Leonard Petrucelli
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

6.  AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation.

Authors:  Win D Cheung; Gerald W Hart
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

7.  Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects.

Authors:  Pascale Barbier; Orgeta Zejneli; Marlène Martinho; Alessia Lasorsa; Valérie Belle; Caroline Smet-Nocca; Philipp O Tsvetkov; François Devred; Isabelle Landrieu
Journal:  Front Aging Neurosci       Date:  2019-08-07       Impact factor: 5.750

Review 8.  Stem cell therapy for Alzheimer's disease.

Authors:  Xin-Yu Liu; Lin-Po Yang; Lan Zhao
Journal:  World J Stem Cells       Date:  2020-08-26       Impact factor: 5.326

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.